Literature DB >> 9845176

Hallucinatory modalities in prelingually deaf schizophrenic patients: a retrospective analysis of 67 cases.

K Schonauer1, D Achtergarde, U Gotthardt, H W Folkerts.   

Abstract

In order to examine the effect of congenital or early acquired deafness on hallucinatory modalities in schizophrenia, we interviewed 67 prelingually deaf schizophrenic patients (using sign language) about their hallucinatory experiences over the entire course of their illness. We also analysed the clinical records of our subjects' previous hospitalizations. In our deaf sample, visual and tactile hallucinations were plainly over-represented as hallucinatory modalities in comparison with hearing schizophrenic samples. Although some patients reported visual hallucinatory perceptions of sign language messages, the hallucinatory reception of meaningful information in deaf patients seems also to remain affiliated to the 'auditory' modality. It was concluded that the different representation of hallucinatory modalities reflects in particular the influence of 'the deaf way' of sensory experience on imagery processes.

Entities:  

Mesh:

Year:  1998        PMID: 9845176     DOI: 10.1111/j.1600-0447.1998.tb10102.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  3 in total

Review 1.  Identifying and assessing psychosis in deaf psychiatric patients.

Authors:  Sarah A Landsberger; David R Diaz
Journal:  Curr Psychiatry Rep       Date:  2011-06       Impact factor: 5.285

Review 2.  The perceptual characteristics of voice-hallucinations in deaf people: insights into the nature of subvocal thought and sensory feedback loops.

Authors:  Joanna R Atkinson
Journal:  Schizophr Bull       Date:  2006-03-01       Impact factor: 9.306

3.  Longitudinal Course of Illness in Congenitally Deaf Patient with Auditory Verbal Hallucination.

Authors:  Yoshihiro Matsumoto; Nobutaka Ayani; Yurinosuke Kitabayashi; Jin Narumoto
Journal:  Case Rep Psychiatry       Date:  2022-02-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.